ArticleThoracic cancer2023

Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib.

Michihiro Kunishige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.